An interventional study of Magnesium Sulfate and Normal saline in Thyroid Neoplasms, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Open to female participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-04-05.
Sponsored by Ajou University School of Medicine · Not applicable, Interventional, and Treatment
The primary purpose of this study is to investigate the effect of intravenous magnesium on postoperative throat pain after thyroidectomy.
The secondary purpose of this study is to investigate the effect of intravenous magnesium on total dose of fentanyl in recovery room after thyroidectomy.
802 studies on the registry are indexed under Thyroid Neoplasms; 216 are open to participants now.
This study's enrollment of 20 is below the median of 51 across 507 interventional studies indexed under Thyroid Neoplasms.
Browse Thyroid Neoplasms studies →Ajou University School of Medicine is the lead sponsor of 171 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
intravenous administration of Magnesium Sulfate
Drug: Magnesium Sulfate
intravenous administration of normal saline
Drug: Normal saline
adminstration of intravenous magnesium as bolus of 50 mg/kg, followed by continuous infusion at rate of 10 mg/kg/h
the same bolus and infusion volumes of normal saline
Throat pain
pain assessment using visual analog scale
Time frame: Up to 48 hours after surgery end
Fentanyl dose in recovery room
Time frame: Up to 30 minutes after surgery end
This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ajou University School of Medicine